| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash | 6,904,185 | |||
| Marketable securities | 3,091,772 | |||
| Prepaid expenses | 1,150,291 | |||
| Total current assets | 11,146,248 | |||
| Technology license | 14,086,999 | |||
| Goodwill | 10,498,539 | |||
| Investment in oravax medical | 1,500,000 | |||
| Total non-current assets | 26,085,538 | |||
| Total assets | 37,231,786 | |||
| Lease liability | 0 | |||
| Trade and other payables | 3,180,662 | |||
| Due to mymd fl shareholders | 29,982 | |||
| Dividends payable | 89,728 | |||
| License fees payable | 337,130 | |||
| Derivative liability | 2,896,000 | |||
| Total current liabilities | 6,533,502 | |||
| Contingent consideration payable, net of current | 9,380,000 | |||
| Total non-current liabilities | 9,380,000 | |||
| Total liabilities | 15,913,502 | |||
| Convertible preferred stock, value-Series FConvertible Preferred Stock | 0 | |||
| Convertible preferred stock discount-Series FConvertible Preferred Stock | 0 | |||
| Convertible preferred stock derivative-Series FConvertible Preferred Stock | 0 | |||
| Convertible preferred stock, value-Series FOne Convertible Preferred Stock | 0 | |||
| Convertible preferred stock discount-Series FOne Convertible Preferred Stock | 0 | |||
| Convertible preferred stock, value-Series GConvertible Preferred Stock | 8,804,000 | |||
| Convertible preferred stock discount-Series GConvertible Preferred Stock | 6,938,000 | |||
| Convertible preferred stock, value-Series HConvertible Preferred Stock | 7,000,000 | |||
| Convertible preferred stock discount-Series HConvertible Preferred Stock | 2,729,083 | |||
| Series h convertible preferred stock derivative-Series HConvertible Preferred Stock | 1,837,000 | |||
| Convertible preferred stock, value-Series IConvertible Preferred Stock | 2,697,977 | |||
| Total mezzanine equity | 6,997,894 | |||
| Preferred stock, value-Series IConvertible Preferred Stock | 0 | |||
| Preferred stock, value-Series DConvertible Preferred Stock | 144,524 | |||
| Common stock, par value 0.001, 1,250,000,000 shares authorized, 2,977,672 and 34,397 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 179,812 | |||
| Additional paid in capital | 151,558,433 | |||
| Accumulated deficit | -137,562,379 | |||
| Total stockholders equity | 14,320,390 | |||
| Total liabilities and stockholders equity | 37,231,786 | |||
Q C TECHNOLOGIES, INC. (QCLS)
Q C TECHNOLOGIES, INC. (QCLS)